E levu na veiqaravi e rawa ni caka me qaravi kina na kenisa ni prostate, ena vakatau ena kena ivakatagedegede kei na kena kaukaua, na bula kei na ka e vinakata o koya e tauvimate.
E so na veiqaravi e dau caka:
1. Na vakadikevi ni kenisa: Na iwalewale oqo e sega ni tekivu totolo kina na veiqaravi, ia e okati kina na vakadikevi kei na vakadidike e caka wasoma.
E rawa ni yaga vei ira na tagane e lailai na kena rivarivabitaki nira na tauvi kenisa ni prostate.
2. Veisele: Na prostatectomy e dua na veisele me kau laivi kina na prostate gland.
E rawa ni caka ena veisele e dola se laparoscopically (vakayagataki na icula lalai kei na iyaya ni veisele e dau vakayagataki vakalevu).
3. Radiation therapy: Na veiqaravi oqo e vakayagataki kina na kaukaua ni biau livaliva me vakamatei kina na sela ni kenisa.
E rawa ni soli e tuba (mai na misini e tiko e taudaku ni yago) se e loma (mai na iyaya e vakacurumi e yasa ni kenisa).
4. Na veiqaravi ni hormone: Na veiqaravi oqo e vakalailaitaka na levu ni hormone ni tagane (androgen) ena yago, e rawa ni tarova se tarova na tete ni kenisa ni prostate.
E rawa ni vakayagataki duadua ga se vakayagataki vata kei na so tale na veiqaravi.
5. Chemotherapy: Na veiqaravi oqo e vakayagataki kina na wainimate me vakamatei kina na sela ni kenisa.
E rawa ni vakayagataki ena kenisa ni prostate sa tete ina so tale na tikiniyago.
6. Immunotherapy: Na veiqaravi oqo e vukei ira na sotia ni yago mera valuta na kenisa.
E rawa ni vakayagataki ena kenisa ni prostate sa sega ni vinaka na kena iwali.
7. Targeted therapy: Na veiqaravi oqo e caka me tara na gene se protein e vukea na tubu kei na bula ni sela ni kenisa.
E rawa ni vakayagataki ena kenisa ni prostate sa sega ni vinaka na kena iwali.
8. Cryotherapy: Na veiqaravi oqo e vakayagataki kina na batabata kaukaua me vakabatabatataka qai vakamatea na sela ni kenisa.
E rawa ni vakayagataki ena kenisa ni prostate e se qai tekivu se kenisa e sa baci basika tale ni oti na kena qaravi.
9. High-intensity focused ultrasound (HIFU): Na veiqaravi oqo e vakayagataki kina na rorogo e kaukaua sara me vakatakatai qai vakarusai kina na sela ni kenisa.
E rawa ni vakayagataki ena kenisa ni prostate e se qai tekivu se kenisa e sa baci basika tale ni oti na kena qaravi.
10. Na wawa: Na iwalewale oqo e okati kina na kena dikevi vakawasoma na kenisa, ia me kua ni tekivu na veiqaravi vakavo ga ke sa laurai na kena ivakatakilakila se veisau.
E rawa ni yaga vei ira na qase e tubu malua tiko na kenisa ni nodra yatevuso kei na so tale na mate bibi.
E bibi me veivosakitaki kei na tabana ni bula na veiqaravi kece e rawa ni caka me kilai kina na veiqaravi vinaka duadua me caka.
Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.
Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.
Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.
Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.
Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.
de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.
Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.
['iVakamacala: veiqaravi vakavuniwai']
['Na website qo e vakarautaki me baleta ga na vuli kei na itukutuku, e sega ni kena inaki me soli kina na ivakasala vakavuniwai se veiqaravi vakavuniwai.']
['Na itukutuku e vakarautaki e sega ni dodonu me vakayagataki me dikevi kina se me qaravi kina e dua na mate, o ira tale ga na via qara ivakasala vakavuniwai mera lai raici vuniwai.']
['Me nanumi tiko ni neural network e dau vakarautaka na isaunitaro e sega ni dau donu ena gauna e cakacakataki kina na iwiliwili, me vaka na kedra iwiliwili na tauvimate.']
['Ke o nanuma ni o tauvimate bibi, qirita na 911 se gole ina vanua ni veiqaravi e voleka vei iko. E sega ni dua na veiwekani e tauyavutaki ena website qo se na kena vakayagataki. E sega ni dua na ka e tukuna se cakava na BioMedLib se o ira na kena tamata cakacaka, se o ira na vakaitavi ena website qo me baleta na itukutuku e tiko kina se na kena vakayagataki.']
['Disclaimer: dodonu ni lavelavetaki']
['Na Digital Millennium Copyright Act ni 1998, 17 U.S.C. § 512 (na DMCA) e vakarautaka na recourse me baleta na itaukei ni dodonu ni lavelavetaki era vakabauta ni iyaya e basika ena Initaneti e voroka na nodra dodonu ena ruku ni lawa ni dodonu ni lavelavetaki ni Amerika. ']
['Ke o vakabauta ni dua na ka e tabaki ena neimami website se na neimami veiqaravi e beci kina na nomu dodonu ni kena maroroi na itukutuku, o iko (se nomu mata) e rawa ni o vakauta mai e dua na notisi mo kerea me kau laivi se me tarovi na kena vakayagataki. ']
['Me vakau na itukutuku ena i-meli (raica na "Veitaratara" ena tabana e baleta na itikotiko ni imeli). ']
['Na DMCA e gadrevi kina na nomu itukutuku ni kena beitaki ni beci na dodonu ni lavelavetaki e oka kina na itukutuku oqo: (1) ivakamacala ni cakacaka ni taqomaki ni dodonu ni lavelavetaki e tukuni ni sa beci; (2) ivakamacala ni lewena e beitaki ni beci kei na itukutuku e veirauti me rawa kina ni da kunea na lewena; (3) itukutuku ni veitaratara me baleti iko, oka kina na nomu itikotiko, naba ni talevoni kei na itikotiko ni imeli; (4) e dua na itukutuku mai vei iko ni o vakabauta ena vakabauta vinaka ni lewena ena kena ivakarau e kudruvaka e sega ni vakadonui mai vua na itaukei ni dodonu ni lavelavetaki, se na kena mata, se ena cakacaka ni dua na lawa; ']
['(5) e dua na nomu ivakamacala, e sainitaki ena itotogi ni bubului lasu, ni dina na itukutuku e volai ena notisi, ni tu tale ga vei iko na dodonu mo valataka na dodonu ni kena taqomaki na ka e volai; ']
['E sega ni dodonu me dua na ka e caka ena kena vakayagataki na Internet.']
['Ke o sega ni vola na itukutuku kece qori, ena rawa ni berabera na kena qaravi na nomu kudru.']
['Veitaratara']
['Yalovinaka vakauta mai na imeli ena dua na taro se vakatutu.']
How to treat prostate cancer?
There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.
Some common treatments include:
1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.
It may be suitable for men with low-risk prostate cancer.
2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.
It can be done through open surgery or laparoscopically (using small incisions and specialized tools).
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).
4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.
It can be used alone or in combination with other treatments.
5. Chemotherapy: This treatment uses drugs to kill cancer cells.
It may be used for advanced prostate cancer that has spread to other parts of the body.
6. Immunotherapy: This treatment helps the immune system fight cancer.
It may be used for advanced prostate cancer that has not responded to other treatments.
7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.
It may be used for advanced prostate cancer that has not responded to other treatments.
8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.
It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.
It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Rauta na']
['Na BioMedLib e vakayagataka na kompiuta (machine-learning algorithms) me bulia na taro kei na kena isau.']
['Eda tekivu ena 35 na milioni na ivola vakavuniwai e tabaki ena PubMed/Medline, kei na tabana ni RefinedWeb.']
